全文获取类型
收费全文 | 1695篇 |
免费 | 115篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 42篇 |
儿科学 | 22篇 |
妇产科学 | 22篇 |
基础医学 | 343篇 |
口腔科学 | 34篇 |
临床医学 | 140篇 |
内科学 | 285篇 |
皮肤病学 | 96篇 |
神经病学 | 185篇 |
特种医学 | 94篇 |
外国民族医学 | 1篇 |
外科学 | 300篇 |
综合类 | 20篇 |
预防医学 | 92篇 |
眼科学 | 12篇 |
药学 | 59篇 |
肿瘤学 | 79篇 |
出版年
2022年 | 10篇 |
2021年 | 31篇 |
2020年 | 10篇 |
2019年 | 22篇 |
2018年 | 33篇 |
2017年 | 23篇 |
2016年 | 27篇 |
2015年 | 33篇 |
2014年 | 50篇 |
2013年 | 57篇 |
2012年 | 63篇 |
2011年 | 82篇 |
2010年 | 45篇 |
2009年 | 43篇 |
2008年 | 65篇 |
2007年 | 87篇 |
2006年 | 67篇 |
2005年 | 60篇 |
2004年 | 46篇 |
2003年 | 60篇 |
2002年 | 70篇 |
2001年 | 59篇 |
2000年 | 55篇 |
1999年 | 64篇 |
1998年 | 35篇 |
1997年 | 30篇 |
1996年 | 23篇 |
1995年 | 30篇 |
1994年 | 14篇 |
1993年 | 15篇 |
1992年 | 19篇 |
1991年 | 33篇 |
1990年 | 21篇 |
1989年 | 27篇 |
1988年 | 24篇 |
1987年 | 32篇 |
1986年 | 33篇 |
1985年 | 24篇 |
1984年 | 14篇 |
1983年 | 15篇 |
1975年 | 11篇 |
1974年 | 11篇 |
1973年 | 14篇 |
1972年 | 12篇 |
1971年 | 16篇 |
1968年 | 12篇 |
1967年 | 14篇 |
1966年 | 9篇 |
1913年 | 16篇 |
1912年 | 20篇 |
排序方式: 共有1826条查询结果,搜索用时 15 毫秒
1.
2.
Hans D de Boer Jan van Egmond Jacques J Driessen Leo HD Booij 《Neuropsychiatric Disease and Treatment》2007,3(5):539-544
Steroidal neuromuscular blocking agents (NMBAs), such as rocuronium, are widely used in clinical anesthesia and emergency medicine to facilitate endotracheal intubation and artificial ventilation and to allow surgical access to body cavities. Reversal of neuromuscular blockade is important for the acceleration of patient recovery and prevention of postoperative residual neuromuscular blockade and reduces the incidence of severe morbidity and mortality associated with anesthesia management. Sugammadex is the first selective relaxant binding agent (SRBA) and has been designed to reverse the steroidal neuromuscular blocking drug rocuronium. Encapsulation of the rocuronium molecule by sugammadex results in a rapid decrease in free rocuronium in the plasma and subsequently at the nicotinic receptor at the motor endplate. After encapsulation, rocuronium is not available to bind to the nicotinic receptor in the neuromuscular junction. This promotes the liberation of acetylcholine receptors, and muscle activity reappears. This new concept of reversal of neuromuscular block induced by rocuronium (or vecuronium) led to impressive results in animal and phase 1 and 2 studies. Sugammadex is currently in phase 3 clinical studies and may be commercially available by 2008. 相似文献
3.
4.
Susan W. Volk VMD PhD ; Antoneta Radu BS ; Liping Zhang MS ; Kenneth W. Liechty MD 《Wound repair and regeneration》2007,15(5):736-747
Chronic wounds create a formidable clinical problem resulting in considerable morbidity and healthcare expenditure. The etiology for wound healing impairment appears to be multifactorial; however, ischemia is a common factor in most types of chronic wounds. Ideal therapy for such wounds would be to correct deficiencies in growth factors and matrix components and provide cellular precursors required for timely wound closure. We hypothesized that stromal progenitor cell (SPC) therapy could correct the ischemic wound-healing defect through both direct and indirect mechanisms. To test this hypothesis, we used the ischemic rabbit ear model of chronic wound healing. We found that treatment of the wounds with SPCs was able to reverse the ischemic wound-healing impairment, with improved granulation tissue formation and reepithelialization compared with vehicle or bone marrow mononuclear cell controls. In vitro, SPCs were found to produce factors involved in angiogenesis and reepithelialization, and extracellular matrix components, providing evidence for both direct and indirect mechanisms for the observed correction of the healing impairment in these wounds. Treatment of ischemic wounds with SPCs can dramatically improve wound healing and provides a rationale for further studies focused on SPCs as a potential cellular therapy in impaired wound healing. 相似文献
5.
L D Holinger M S Volk G F Tucker 《The Annals of otology, rhinology, and laryngology》1987,96(5):505-508
Forty-eight cases of tracheal agenesis have been reported to date. Previous authors have studied gross postmortem laryngeal specimens. Of 37 cases wherein laryngeal findings were mentioned, only 14 were reported to be abnormal. This report details two more cases of tracheal agenesis and includes a detailed histopathologic study of the laryngeal anomalies by serial horizontal section. Although one of these specimens appeared normal at autopsy, both were found to have several abnormalities when studied microscopically in horizontal section. Both have an elliptical cricoid cartilage, an abnormality originally discovered by one of us (G.F.T.) using the same technique. 相似文献
6.
Monoclonal Antibody Specific for TIRC7 Induces Donor-specific Anergy and Prevents Rejection of Cardiac Allografts in Mice 总被引:1,自引:0,他引:1
Yusuke Kumamoto Antje Tomschegg Fatima Bennai-Sanfourche Anke Boerner Arthur Kaser Isabella Schmidt-Knosalla Thomas Heinemann Mirko Schlawinsky Richard S. Blumberg Hans-Dieter Volk Nalan Utku 《American journal of transplantation》2004,4(4):505-514
T cell immune response c-DNA (TIRC7) is up-regulated during the early stages of T-cell activation in response to alloantigens. In this study, we analyzed the effects of newly developed monoclonal antibodies (mAb) against TIRC7 in acute cardiac allograft rejection. Fully vascularized heterotopic allogeneic heart transplantation was performed in mice across a full-mismatch barrier (C57Bl/10 into CBA). Recipients received seven injections (day 0-7) of a novel anti-TIRC7 mAb or remained untreated. Graft survival, histology and ex vivo lymphocyte functions were tested. Targeting of TIRC7 with an anti-TIRC7 mAb diminishes lymphocyte infiltration into grafts resulting in delay of morphological graft damage and prolongation of allograft survival. The lymphocytes from anti-TIRC7 mAb-treated animals exhibit hypo-responsiveness without evidence of lymphocyte depletion against the donor allo-antigens. Proliferation and expression of interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) were down-regulated while interleukin-4 (IL-4) and IL-10 expression were spared. Moreover, anti-TIRC7 mAb enhanced up-regulation of CTLA-4 expression but suppressed up-regulation of CD25 on stimulated lymphocytes in vitro and in vivo. Ligation of TIRC7 has important effects on the regulation of co-stimulatory signaling pathways associated with suppressing of T-cell activation. Targeting of TIRC7 may therefore provide a novel therapeutic approach for modulating T cell immune responses during organ transplantation. 相似文献
7.
Mice treated intraperitoneally with zymosan showed a strong inhibition of the DTHR (delayed-type hypersensitivity reaction) against sheep erythrocytes (SE), ovalbumin (OA), and alloantigen. Furthermore, the rejection time of skin transplants was nearly doubled while antibody formation against SE was significantly enhanced. When a DTHR against OA and an antibody formation against SE were induced at the same time in the same animals, than the suppressive and stimulating effects cancelled each other. These results are discussed with regard to the sensitivity of lymphocyte subpopulations, which may be different if exposed to phagocytosis-induced oxygen radicals. 相似文献
8.
In vitro and in vivo precipitation of iodinated contrast agents when ioxaglate and papaverine are given together has been reported. To verify these reports and to investigate other medications not previously tested, the authors analyzed mixtures of contrast agents and medications in vitro with a light spectrophotometer and observed them for visible precipitates for up to 120 minutes. Previously reported incompatibilities between ionic or low-osmolality contrast media and medications were verified, and several new incompatibilities were discovered. No incompatibilities were found when the drugs tested were mixed with the new nonionic contrast media. 相似文献
9.
10.